10/26/2021 | News release | Distributed by Public on 10/26/2021 08:22
Penn State Health will begin offering eligible employees FDA-authorized Moderna booster doses - half of the dose that is administered for a primary series.
Penn State Health will begin offering the Moderna booster shot to eligible employees this week, following the U.S. Food and Drug Administration's (FDA) Oct. 20 amendment of its emergency use authorizations for both the Moderna and Johnson & Johnson's Janssen COVID-19 vaccines to allow a single booster dose.
October 26, 2021Penn State Health Daily Brief
As with Pfizer, the Moderna booster shot may be administered at least six months after the completion of the initial mRNA vaccine series, or two months following an initial dose of Johnson & Johnson's Janssen COVID-19 vaccine, based on these recommendations from the Centers for Disease Control and Prevention.
Eligible employees may sign up here to receive their Moderna booster shots at the following locations:
The FDA has authorized the use of a heterologous - "mix and match" - booster dose for all three currently available COVID-19 vaccines. Penn State Health is not administering Johnson & Johnson boosters. Instead, any eligible employee who received the Johnson & Johnson vaccine elsewhere may now receive a booster dose of the Pfizer or Moderna vaccine through Penn State Health.
For additional information about COVID-19 booster shots, see the FAQs on the Penn State Health COVID-19 vaccine website.
If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.